DOCSLIB.ORG

Ethylene Glycol and Propylene Glycol Toxicity

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM) Ethylene Glycol and Propylene Glycol Toxicity Course: WB 4342 CE Original Date: March 20, 2020 CE Expiration Date: March 20, 2022 Key • Ethylene glycol ingestion first affects the central Concepts nervous system (CNS). After a characteristic latent period, toxic metabolites might produce signs of inebriation followed by serious illness and even death. • No studies were located regarding a link between ethylene glycol exposure and cancer or reproductive or developmental hazards in humans. • Propylene glycol is much less toxic than ethylene glycol. About This This educational case study is one in a series of self- and Other instructional modules designed to increase the primary Case Studies care provider’s knowledge of hazardous substances in the in environment. The modules also promote adoption of Environment medical practices that aid in the evaluation and care of al Medicine potentially exposed patients. You can access the complete series of Case Studies in Environmental Medicine on the Agency for Toxic Substances and Disease Registry (ATSDR) website at URL: https://www.atsdr.cdc.gov/emes/health_professionals/ind ex.html. A downloadable PDF version of this educational series and other environmental medicine materials provides content in an electronic, printable format, especially for those who might lack adequate Internet service. Page 1 of 124 Acknowledgments We gratefully acknowledge the work of the medical writers, editors, and reviewers in producing this educational resource. Listed below are the contributors to this version of the Case Study in Environmental Medicine. Please Note: Each content expert for this case study has indicated that he or she has no conflict of interest to disclose that would bias the case study content. ATSDR Authors: Dianyi Yu, MD ATSDR Planners: Charlton Coles, PhD; Sharon L. Hall, PhD; Delene Roberts MSMHC; Julia Smith, MPH, CHES; Germania Pinheiro MD, MSc, PhD; Dianyi Yu, MD Peer Reviewers: Obaid Faroon, DVM, PhD, and Ki Moon Bang, PhD, MPH ATSDR Commenters: Alaina Steck, MD How to Apply for In order to receive continuing education (CE) for and Receive WB4342 - ATSDR CSEM: Ethylene Glycol/Propylene Continuing Glycol Toxicity please visit TCEO and follow these 9 Education Credit Simple Steps before March 20, 2020. Including the Assessment and Complete the activity Posttest Complete the Evaluation at www.cdc.gov/GetCE Pass the posttest at ___80___% at www.cdc.gov/GetCE To receive free continuing education, please visit the CSEM Ethylene Glycol/Propylene Glycol Toxicity registration page Page 2 of 124 Accrediting Credits Offered Organization The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. CME The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE The Centers for Disease Control and Prevention designates this activity for 1.6 nursing contact hours. CEU The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU's for this program. CECH Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. Continuing Competency credits available are 0. CDC provider number 98614. Page 3 of 124 CPH The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program. Disclaimer and Disclaimer Disclosure What we know about treating patients potentially exposed to hazardous substances in the environment is constantly evolving and is often uncertain. In developing its educational products, the Agency for Toxic Substances and Disease Registry (ATSDR) has worked hard to ensure the accuracy and the currency of the presented information. However, ATSDR makes no claim that the environmental medicine and health education resources discussed in these products comprehensively address all possible situations related to various substances. These products are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients potentially exposed to hazardous substances. The products are not a substitute for a healthcare provider's professional judgment. Please interpret the environmental medicine and the health education resources in light of specific information regarding the patient and in conjunction with other medical authorities. Use of trade names in ATSDR products is for identification purposes only and does not imply endorsement by the ATSDR or the U.S. Department of Health and Human Services. Disclosure In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. Page 4 of 124 CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept commercial support for this continuing education activity. U.S. Department of Health and Human Services Agency for Toxic Substances and Disease Registry Division of Toxicology and Human Health Sciences Environmental Medicine Branch Page 5 of 124 Table of Contents How to Use This Course ......................................................................... 7 What Is Ethylene Glycol? ..................................................................... 13 Where Is Ethylene Glycol Found? .......................................................... 23 What Are Routes of Exposure to Ethylene Glycol? ................................... 26 Who is at Risk of Exposure to Ethylene Glycol?.......................................30 What Are U.S. Regulations and Guidelines for Ethylene Glycol Exposure?... 36 What Is the Biological Fate of Ethylene Glycol? ....................................... 39 What Are the Toxicological Effects of Ethylene Glycol Poisoning? .............. 43 Clinical Assessment—History and Physical Examination ........................... 56 Clinical Assessment—Laboratory Tests .................................................. 69 How Should Patients Exposed to Ethylene Glycol Be Treated and Managed? 7979 What Is Propylene Glycol? ................................................................... 87 What Instructions Should You Give to Patients Regarding Ethylene Glycol/Propylene Glycol Exposure? ........................................................ 98 Sources of Additional Information ....................................................... 100 Posttest ........................................................................................... 107 Literature Cited ............................................................................... 112 Page 6 of 124 How to Use This Course Introduction Case Studies in Environmental Medicine’s goal is to increase the primary care provider’s knowledge of hazardous substances in the environment and to help in evaluation and treating of potentially exposed patients. This case study focuses on ethylene glycol and propylene glycol toxicity. Availability Two versions of the Ethylene Glycol/Propylene Glycol Toxicity CSEM are available. • The HTML version (To be added after clearance during Web production) provides content through the Internet. • The downloadable PDF version (To be added after clearance during web production) provides content in an electronic, printable format, especially for those who might lack adequate Internet service. • The HTML version offers interactive exercises and prescriptive feedback to the user. Instructions Follow these steps to make the most effective use of this course: • Take the Initial Check to assess your current knowledge about ethylene glycol and propylene glycol toxicity. • Read the title, learning objectives, text, and key points in each section. • Complete the progress check exercises at the end of each section and check your answers. • Complete and submit your assessment and posttest response online if you want continuing education credit. You can print continuing education certificates immediately after course completion. Page 7 of 124 Instructional This course is designed to help you learn efficiently. Format Topics are clearly labeled; you can skip
Recommended publications
  • News and Notes 97

    News and Notes 97

    96 Injury Prevention 1998;4:96–97 ... while in Canada, helmet laws nated eVorts. It sets targets for the reduction Inj Prev: first published as 10.1136/ip.4.2.96 on 1 June 1998. Downloaded from knocked of deaths and injuries requiring hospitalisa- NEWS AND tion for traYc collisions, fires, drownings, and As summer approached, the debate over those in the workplace and home. Recognis- NOTES bicycle helmets in Canada was heating up. ing the lack of information on sport and rec- Countering a growing movement to get reational injuries the report notes that this helmet laws passed in every province is an area requires further attention. Further details: organization called the Ontario Coalition for Minister’s Injury Prevention Committee, c/o Better Cycling whose web site applauds the OYce for Injury Prevention, Environmental Revised injury control manual from failures of helmet law lobbyists and the Health Assessment and Safety Branch, BC Ministry of Health, 7-1 1515 Blanshard AAP watering down of Ontario’s law (only cyclists younger than 18 must wear helmets or face a Street, Victoria BC V8V 3C8, Canada (fax: The new injury control manual from the fine in that province). The group argues that +1 250 952 1342). American Academy of Pediatrics (AAP) is the government should instead mandate now available and by all accounts is well cycling education in schools, on the grounds Our Healthier Nation worth looking at. It contains new chapters on that more crashes and injuries can be violence, sports injuries, agricultural injuries, prevented “by getting children to appreciate A Contract for Health is how the UK govern- the need to cycle responsibly”.
  • Use of Solvents for Pahs Extraction and Enhancement of the Pahs Bioremediation in Coal- Tar-Contaminated Soils Pak-Hing Lee Iowa State University

    Use of Solvents for Pahs Extraction and Enhancement of the Pahs Bioremediation in Coal- Tar-Contaminated Soils Pak-Hing Lee Iowa State University

    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2000 Use of solvents for PAHs extraction and enhancement of the PAHs bioremediation in coal- tar-contaminated soils Pak-Hing Lee Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Environmental Engineering Commons Recommended Citation Lee, Pak-Hing, "Use of solvents for PAHs extraction and enhancement of the PAHs bioremediation in coal-tar-contaminated soils " (2000). Retrospective Theses and Dissertations. 13912. https://lib.dr.iastate.edu/rtd/13912 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter fece, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quaiity of the copy submitted. Broken or indistinct print colored or poor quality illustrations and photographs, print bleedthrough, substeindard margins, and improper alignment can adversely affect reproduction. In the unlilcely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
  • Manganese and Its Compounds: Environmental Aspects

    Manganese and Its Compounds: Environmental Aspects

    This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the United Nations Environment Programme, the International Labour Organization, or the World Health Organization. Concise International Chemical Assessment Document 63 MANGANESE AND ITS COMPOUNDS: ENVIRONMENTAL ASPECTS First draft prepared by Mr P.D. Howe, Mr H.M. Malcolm, and Dr S. Dobson, Centre for Ecology & Hydrology, Monks Wood, United Kingdom The layout and pagination of this pdf file are not identical to the document in print Corrigenda published by 12 April 2005 have been incorporated in this file Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organization, and the World Health Organization, and produced within the framework of the Inter-Organization Programme for the Sound Management of Chemicals. World Health Organization Geneva, 2004 The International Programme on Chemical Safety (IPCS), established in 1980, is a joint venture of the United Nations Environment Programme (UNEP), the International Labour Organization (ILO), and the World Health Organization (WHO). The overall objectives of the IPCS are to establish the scientific basis for assessment of the risk to human health and the environment from expos ure to chemicals, through international peer review processes, as a prerequisite for the promotion of chemical safety, and to provide technical assistance in strengthening national capacities for the sound management
  • HISTORY of LEAD POISONING in the WORLD Dr. Herbert L. Needleman Introduction the Center for Disease Control Classified the Cause

    HISTORY of LEAD POISONING in the WORLD Dr. Herbert L. Needleman Introduction the Center for Disease Control Classified the Cause

    HISTORY OF LEAD POISONING IN THE WORLD Dr. Herbert L. Needleman Introduction The Center for Disease Control classified the causes of disease and death as follows: 50 % due to unhealthy life styles 25 % due to environment 25% due to innate biology and 25% due to inadequate health care. Lead poisoning is an environmental disease, but it is also a disease of life style. Lead is one of the best-studied toxic substances, and as a result we know more about the adverse health effects of lead than virtually any other chemical. The health problems caused by lead have been well documented over a wide range of exposures on every continent. The advancements in technology have made it possible to research lead exposure down to very low levels approaching the limits of detection. We clearly know how it gets into the body and the harm it causes once it is ingested, and most importantly, how to prevent it! Using advanced technology, we can trace the evolution of lead into our environment and discover the health damage resulting from its exposure. Early History Lead is a normal constituent of the earth’s crust, with trace amounts found naturally in soil, plants, and water. If left undisturbed, lead is practically immobile. However, once mined and transformed into man-made products, which are dispersed throughout the environment, lead becomes highly toxic. Solely as a result of man’s actions, lead has become the most widely scattered toxic metal in the world. Unfortunately for people, lead has a long environmental persistence and never looses its toxic potential, if ingested.
  • The Synthesis of Fluorescent 3, 6-Dihydroxyxanthones

    The Synthesis of Fluorescent 3, 6-Dihydroxyxanthones

    University of Wisconsin Milwaukee UWM Digital Commons Theses and Dissertations August 2016 The yS nthesis of Fluorescent 3, 6-dihydroxyxanthones: A Route to Substituted Fluoresceins Surajudeen Omolabake University of Wisconsin-Milwaukee Follow this and additional works at: https://dc.uwm.edu/etd Part of the Chemistry Commons Recommended Citation Omolabake, Surajudeen, "The yS nthesis of Fluorescent 3, 6-dihydroxyxanthones: A Route to Substituted Fluoresceins" (2016). Theses and Dissertations. 1299. https://dc.uwm.edu/etd/1299 This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UWM Digital Commons. For more information, please contact [email protected]. THE SYNTHESIS OF FLUORESCENT 3, 6-DIHYDROXYXANTHONES: A ROUTE TO SUBSTITUTED FLUORESCEINS by Surajudeen Omolabake A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science In Chemistry at University of Wisconsin-Milwaukee August 2016 ABSTRACT THE SYNTHESIS OF FLUORESCENT 3, 6-DIHYDROXYXANTHONES: A ROUTE TO SUBSTITUTED FLUORESCEIN by Surajudeen Omolabake University of Wisconsin-Milwaukee, 2016 Under the Supervision of Professor Alan W Schwabacher Xanthones belong to the family of compounds of the dibenzo-γ-pyrone framework. Naturally occurring xanthones have been reported to show a wide range of biological and medicinal activities including antifungal,19 antimalarial,20 antimicrobial,21 antiparasitic,22 anticancer,23 and inhibition of HIV activity in cells.24 Xanthones have also been used as a turn on fluorescent probe for metal ions,32 including use as pH indicators, metal ion sensors, in molecular biology, medicinal chemistry and in the construction of other dyes.
  • Safer Cocktail for an Ethanol/Water/Ammonia Solvent

    Safer Cocktail for an Ethanol/Water/Ammonia Solvent

    L A S C P LSC in Practice C P O C L Safer Cocktail for an Ethanol/Water/ K T I A I C Ammonia Solvent Mixture L S A Problem T A laboratory had been under pressure to move towards Using this mixture, the sample uptake capacity of I the newer generation of safer liquid scintillation ULTIMA-Flo AP, ULTIMA-Flo M and ULTIMA Gold O cocktails. Unfortunately, the sample composition of LLT (PerkinElmer 6013599, 6013579 and 6013377, one of their targets kept giving the researchers problems. respectively) at 20 °C was determined and N Before the lead researcher contacted PerkinElmer, the results were: they had tried PerkinElmer’s Opti-Fluor®, ULTIMA ULTIMA-Flo AP 4.00 mL in 10 mL cocktail N Gold LLT, and ULTIMA Gold XR. All of the safer O ™ ULTIMA-Flo M 4.25 mL in 10 mL cocktail cocktails could incorporate each of the constituents T as indicated by their sample capacity graphs. ULTIMA Gold LLT 4.25 mL in 10 mL cocktail E The problematic sample was an extraction solvent From these results, we observed that it was possible consisting of 900 mL ethanol, 50 mL ammonium to get 4.0 mL of the sample into all of these cocktails. hydroxide, 500 mL water and an enzyme containing In addition, we determined that it was not possible to 14C. The mixture had a pH in the range of 10 to 11. get 4 mL sample into 7 mL of any of these cocktails. To complete this work, we also checked for lumines- Discussion cence using 4 mL of sample in 10 mL of each cocktail.
  • Approach to the Poisoned Patient

    Approach to the Poisoned Patient

    PED-1407 Chocolate to Crystal Methamphetamine to the Cinnamon Challenge - Emergency Approach to the Intoxicated Child BLS 08 / ALS 75 / 1.5 CEU Target Audience: All Pediatric and adolescent ingestions are common reasons for 911 dispatches and emergency department visits. With greater availability of medications and drugs, healthcare professionals need to stay sharp on current trends in medical toxicology. This lecture examines mind altering substances, initial prehospital approach to toxicology and stabilization for transport, poison control center resources, and ultimate emergency department and intensive care management. Pediatric Toxicology Dr. James Burhop Pediatric Emergency Medicine Children’s Hospital of the Kings Daughters Objectives • Epidemiology • History of Poisoning • Review initial assessment of the child with a possible ingestion • General management principles for toxic exposures • Case Based (12 common pediatric cases) • Emerging drugs of abuse • Cathinones, Synthetics, Salvia, Maxy/MCAT, 25I, Kratom Epidemiology • 55 Poison Centers serving 295 million people • 2.3 million exposures in 2011 – 39% are children younger than 3 years – 52% in children younger than 6 years • 1-800-222-1222 2011 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System Introduction • 95% decline in the number of pediatric poisoning deaths since 1960 – child resistant packaging – heightened parental awareness – more sophisticated interventions – poison control centers Epidemiology • Unintentional (1-2
  • A Brief Guide to Authors

    A Brief Guide to Authors

    Latvian Journal of Chemistry, No. 1/2, 2011, 139–144. DOI 10.2478/v10161-011-0059-3 CYCLODEHYDRATION OF DIOLS IN ACIDIC IONIC LIQUIDS E. Ausekle, A. Priksane, A. Zicmanis Faculty of Chemistry, University of Latvia, Kr. Valdemara Str. 48, Riga, LV-1013 e-mail: [email protected] In the presence of sulfonic acid group functionalized Bronsted-acidic ionic liquids, cyclodehydration of 1,2-ethanediol and 1,4-butanediol is investigated. The role of structure and catalytic activity of ionic liquids on the formation of cyclic ethers: 1,4-dioxane and tetrahydrofuran – is de- termined. Key words: acidic ionic liquids, ethylene glycol, 1,4-butanediol, cyclodehydration, 1,4-dioxane, tetrahydrofuran. INTRODUCTION During the last decades, ionic liquids are extensively used in organic syn- thesis as solvents and catalysts [1, 2]. Bronsted-acidic ionic liquids (AILs) are used as substitutes of mineral and organic acids in acid-catalyzed reactions like esterification, etherification, pinacol–pinacolone rearrangement, condensation etc. [3–6]. Bronsted-acidic ionic liquids have good proton donor properties comparable with mineral acids. AILs as catalysts are non-corrosive, non-volati- le, immiscible with many organic solvents, and they can be recycled and reused [7]. To determine their productivity in diol cyclodehydration, two diols: 1,2- ethanediol (ethylene glycol) and 1,4-butanediol are used. Cyclodehydration of both diols leads to formation of industrially significant cyclic ethers: 1,4-di- oxane and tetrahydrofuran (THF). 1,4-Dioxane and THF are widely used as organic solvents. Tetrahydrofuran is a useful solvent for organic synthesis, production of natural and synthetic resins, and also is a valuable intermediate in manufacture of a number of chemicals and plastics.
  • Pathophysiology of Acid Base Balance: the Theory Practice Relationship

    Pathophysiology of Acid Base Balance: the Theory Practice Relationship

    Intensive and Critical Care Nursing (2008) 24, 28—40 ORIGINAL ARTICLE Pathophysiology of acid base balance: The theory practice relationship Sharon L. Edwards ∗ Buckinghamshire Chilterns University College, Chalfont Campus, Newland Park, Gorelands Lane, Chalfont St. Giles, Buckinghamshire HP8 4AD, United Kingdom Accepted 13 May 2007 KEYWORDS Summary There are many disorders/diseases that lead to changes in acid base Acid base balance; balance. These conditions are not rare or uncommon in clinical practice, but every- Arterial blood gases; day occurrences on the ward or in critical care. Conditions such as asthma, chronic Acidosis; obstructive pulmonary disease (bronchitis or emphasaemia), diabetic ketoacidosis, Alkalosis renal disease or failure, any type of shock (sepsis, anaphylaxsis, neurogenic, cardio- genic, hypovolaemia), stress or anxiety which can lead to hyperventilation, and some drugs (sedatives, opoids) leading to reduced ventilation. In addition, some symptoms of disease can cause vomiting and diarrhoea, which effects acid base balance. It is imperative that critical care nurses are aware of changes that occur in relation to altered physiology, leading to an understanding of the changes in patients’ condition that are observed, and why the administration of some immediate therapies such as oxygen is imperative. © 2007 Elsevier Ltd. All rights reserved. Introduction the essential concepts of acid base physiology is necessary so that quick and correct diagnosis can The implications for practice with regards to be determined and appropriate treatment imple- acid base physiology are separated into respi- mented. ratory acidosis and alkalosis, metabolic acidosis The homeostatic imbalances of acid base are and alkalosis, observed in patients with differing examined as the body attempts to maintain pH bal- aetiologies.
  • Cardiac Dysfunction and Lactic Acidosis During Hyperdynamic and Hypovolemic Shock

    Cardiac Dysfunction and Lactic Acidosis During Hyperdynamic and Hypovolemic Shock

    è - \-o(J THESIS FOR TIIE DEGREE OF DOCTOR OF MEDICINE CARDIAC DYSFUNCTION AND LACTIC ACIDOSIS DURING HYPERDYNAMIC AND HYPOVOLEMIC SHOCK DAVID JAMES COOPER DEPARTMENT OF ANAESTIIESIA AND INTENSIVE CARE FACULTY OF MEDICINE UNIVERSITY OF ADELAIDE Submitted: October,1995 Submitted in revised form: November, 1996 2 J TABLE OF CONTENTS Page 5 CH 1(1.1) Abstract (1.2) Signed statement (1.3) Authors contribution to each publication (1.4) Acknowledgments (1.5) Publications arising 9 CH2Introduction (2.1) Shock and lactic acidosis (2.2) Cardiac dysfunction and therapies during lactic acidosis (2.3) Cardiac dysfunction during hyperdynamic shock (2.4) Cardiac dysfunction during hypovolemic shock (2.5) Cardiac dysfunction during ionised hypocalcaemia l7 CH3 Methods (3. 1) Left ventricular function assessment - introduction (3.2) Left ventricular function assessment in an animal model 3.2.I Introduction 3.2.2 Anaesthesia 3.2.3 Instrumentation 3.2.4 Systolic left ventricular contractility 3.2.5 Left ventricular diastolic mechanics 3.2.6 Yentricular function curves 3.2.1 Limitations of the animal model (3.3) Left ventricular function assessment in human volunteers 3.3.7 Left ventricular end-systolic pressure measurement 3.3.2 Left ventricular dimension measurement 3.3.3 Rate corrected velocity of circumferential fibre shortening (v"¡.) 3.3.4. Left ventricular end-systolic meridional wall stress (o"r) 4 33 CH 4 Cardiac dysfunction during lactic acidosis (4.1) Introduction 4.7.1 Case report (4.2) Human studies 4.2.1 Bicarbonate in critically ill patients
  • 1,4-Dioxane Priority Existing Chemical No

    1,4-Dioxane Priority Existing Chemical No

    National Industrial Chemicals Notification and Assessment Scheme 1,4-Dioxane Priority Existing Chemical No. 7 __________________________________ Full Public Report June 1998 © Commonwealth of Australia 1998 ISBN 0 642 47104 5 This work is copyright. Apart from any use permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from AusInfo. Requests and inquiries concerning reproduction and rights should be addressed to the Manager, Legislative Services, AusInfo, GPO Box 84, Canberra, ACT 2601. ii Priority Existing Chemical Number 7 Preface This assessment was carried out under the National Industrial Chemicals Notification and Assessment Scheme (NICNAS). This Scheme was established by the Industrial Chemicals (Notification and Assessment) Act 1989 (the Act), which came into operation on 17 July 1990. The principal aim of NICNAS is to aid in the protection of people at work, the public and the environment from the harmful effects of industrial chemicals, by assessing the risks associated with these chemicals. NICNAS is administered by the National Occupational Health and Safety Commission (NOHSC) and assessments are carried out in conjunction with Environment Australia (EA) and the Therapeutic Goods Administration (TGA), who carry out the environmental and public health assessments, respectively. NICNAS has two major programs: one focusing on the risks associated with new chemicals prior to importation or manufacture; and the other focussing on existing chemicals already in use in Australia. As there are many thousands of existing industrial chemicals in use in Australia, NICNAS has an established mechanism for prioritising and declaring chemicals as Priority Existing Chemicals (PECs). This Full Public PEC report has been prepared by the Director (Chemicals Notification and Assessment) in accordance with the Act.
  • Use of Immunofluorescence and Viability Stains in Quality Control1

    Use of Immunofluorescence and Viability Stains in Quality Control1

    Use of Immunofluorescence and Viability Stains in Quality Control1 M. J. CHILVER, J. HARRISON, and T. J. B. WEBB, Process Research Department, Allied Breweries Production Limited, Burton-on- Trent, Staffordshire, England DEM IBZ ABSTRACT has been the failure to differentiate live and dead cells. We have been studying the combined use of immunofluorescent and Immunofluorescence has been evaluated as a rapid quality control viability stains so that live and dead, culture and wild yeasts, can be technique for the detection of low levels of wild yeasts in culture yeast or differentiated on the same slide field. This paper details the results other brewery samples. Antisera have been prepared against antigenic groups A to F, pooled and absorbed with culture yeast. Using the indirect obtained when yeast samples are examined alternately with FITC- staining method and fluorescein isothiocyanate or rhodamine as exciting blue light wavelengths and rhodamine-exciting green light fluorochrome, levels as low as 10 wild yeasts per million cells can be detected and when incident fluorescent light is combined with transmitted in three hours. Combined immunofluorescence and viability staining allows white light to illuminate the specimen. the differentiation of live and dead, culture and wild yeast cells, on the same The potential use of fluorescein diacetate as a viability stain has slide by alternating the light sources. The preferred method uses fluorescein been established. Initial work by Rotman and Papermaster (22) isothiocyanate, excited by incident blue light, for wild yeast detection, was developed by Paton and Jones (21) and its use in brewery combined with methylene blue, viewed by transmitted light, for viability quality control has been described by Molzahn and Portno (19).